Shahrzad
Forouzanfar
a,
Iman
Khakpour
b,
Fahmida
Alam
a,
Nezih
Pala
a and
Chunlei
Wang
*bc
aDepartment of Electrical and Computer Engineering, Florida International University, USA
bDepartment of Mechanical and Materials Engineering, Florida International University, USA
cCenter for Study of Matter at Extreme Conditions, Florida International University, USA
First published on 12th August 2021
Label-free aptasensors can be a promising point-of-care biosensor for detecting various cancer diseases due to their selectivity, sensitivity, and lower cost of production and operation. In this study, a highly sensitive aptasensor based on gold-covered polyethylene terephthalate electrodes (PET/Au) decorated with bipolar exfoliated graphene is proposed as a possible contender for disposable label-free aptasensor applications. Bipolar electrochemical exfoliation enables simultaneous exfoliation, reduction, and deposition of graphene nanosheets on prospective electrodes. Our comparative study confirms that the bipolar exfoliated graphene deposited on the negative feeding electrode (i.e., reduced graphene oxide) possesses better electrochemical properties for aptasensing. The optimized aptasensor based on bipolar exfoliated graphene deposited on PET/Au electrodes exhibits a highly sensitive response of 4.07 μA logc−1 (unit of c, pM) which is linear in the range of 0.0007–20 nM, and has a low limit of detection of 0.65 pM (S/N = 3). The aptasensor establishes highly selective performance with a stability of 91.2% after 6 days. This study demonstrates that bipolar electrochemistry is a simple yet efficient technique that could provide high-quality graphene for biosensing applications. Considering its simplicity and efficiency, the BPE technique promises the development of feasible and affordable lab-on-chip and point-of-care cancer diagnosis technologies.
The price of sensing units is one of the major concerns in developing feasible POC biosensors. The envisioned sensing unit should be accurate and yet inexpensive enough to rationalize its installment for on-site applications. Combining label-free detection with economically efficient manufacturing techniques can be a viable option for developing versatile sensing systems to detect and monitor different bio-targets, including PDGF-BB. Thus far, noticeable attention has been devoted to developing cheap and disposable electrochemical biosensors. Various substrates such as paper, polymers (e.g., polyethylene terephthalate), and screen-printed carbon electrodes have been used for developing disposable biosensors.11–15 For instance, Wang et al. demonstrated disposable paper-based label-free cancer biomarker aptasensors in which paper-based electrodes were functionalized with amino-treated graphene, gold nanoparticles, and Prussian blue. The proposed disposable aptasensors showed good sensing performances with linear ranges of 0.01–500 ng mL−1 for carcinoembryonic antigens and a limit of detection (LoD) of 2 pg mL−1.11 Yaman et al. proposed label-free cancer cell aptasensors based on pencil graphite electrodes. The developed aptasensors were functionalized with diphenyl alaninamide-based peptide nanoparticles and DLD-1 cancer cell affinity aptamers. The disposable pencil graphite aptasensor exhibited a good linear range ranging from 2 × 102 to 2.0 × 105 cells per mL with a LoD of 100 cells per mL.16 The proposed disposable label-free cancer aptasensors illustrate the high potential of this class of aptasensors as cancer biomarker disposable POC aptasensors.
Furthermore, the emergence of the COVID-19 pandemic in early 2020 highlighted the importance of fast, reliable, and affordable POC biosensors suitable for the detection of various biotargets (e.g., SARS-CoV-2). The integration of artificial intelligence (AI) and internet of things (IoT) with POC pathogen biosensors has shown that POC biosensors can be effectively used for performing personalized diagnostics under desired conditions and at desired locations, helping the management of the epidemic in an economic and timely manner.17–19 Hence, the authors believe that integration of AI and IoT with cancer biomarker POC biosensors could be an effective strategy to make a significant impact on the diagnosis and management of cancer.
Since the discovery of graphene in the early 2000s, it has attracted massive attention in various domains because of its unique features.20 The large surface area, high thermal conductivity and charge mobility, the wide electrochemical window, and unconventional superconductivity of graphene made this material a potent candidate for the development of biosensors.21,22 The conventional application of graphene for biosensors involves synthesis of graphene with wet chemical processes (e.g., Hummers) or electrochemical approaches, reduction of exfoliated graphene oxide (GO) to reduced graphene oxide (rGO), and its deposition on the desired biosensing electrode.23 Wet chemical synthesis requires harsh oxidizing agents such as KMnO4, NaNO3, and KClO3 in strong acidic agents such as hydrohalic acid and hydrazine.24–27 The application of harsh chemicals can be limited by using electrochemical approaches; however, there could be non-desired functional groups and basal plane damage during anodic exfoliation.28–30 Furthermore, a comparative study by Kauling et al. demonstrated that commercially available graphene (from 60 different vendors worldwide) has a low graphene content (less than 10% in most products and not more than 50% in the highest quality products available ), which illustrates the reason why commercial graphene-based devices are not commonly available yet.31 Nonetheless, conventional methods for synthesis and deposition of GO and rGO cannot simultaneously exfoliate, reduce, and deposit GO and rGO in an environmentally friendly fashion. Such a combination can be achieved via bipolar electrochemistry.32 In addition, Khakpour et al. demonstrated that the bipolar exfoliated rGO has a vertically aligned morphology, which could eliminate the necessity of using spacers such as carbon nanotubes to prevent the aggregation of graphene nano-flakes.33–35
Herein, the novel application of bipolar exfoliation of graphene for a disposable label-free PDGF-BB aptasensor is presented. There are no reports on applying bipolar exfoliated (BPE) graphene for biosensor applications to the best of our knowledge. The bipolar exfoliation method presented in this study is a direct single-step of exfoliation, deposition, and reduction of graphene utilizing a graphite rod in deionized water (DIW). The process of bipolar exfoliation includes applying a constant electric field between two conductive feeder electrodes, which aggregates in opposite polarizations of the graphite rods. Consequently, if the apparent electrical field is strong enough, simultaneous faradaic reactions of reduction at the cathodic pole and oxidation at the anodic pole would occur.32 Thus far, BPE has been demonstrated for various applications due to the simplicity of the setup and lower cost of the process.33,36–38
In this study, BPE-graphene was deposited on stainless steel (SS) electrodes and gold-covered polyethylene terephthalate electrodes (PET/Au) for a comparative study and as the proposed disposable biosensor, respectively. The analysis confirmed that the BPE-rGO deposited on the cathodic (i.e., negative) feeding electrode is highly suitable for aptasensing applications. Thus, PET/Au was used as the negative feeding electrode. The amino-terminated PDGF-BB affinity aptamers were covalently immobilized on BPE-graphene deposited on SS and PET/Au electrodes. The BPE-graphene crystal structure and its morphology were studied via transmission electron microscopy (TEM) and scanning electron microscopy (SEM), respectively. The characteristics of the fabricated BPE-based aptasensors were studied using Fourier-transform infrared spectroscopy (FTIR). Electrochemical and sensing performance analyses were conducted using differential pulse voltammetry (DPV) and cyclic voltammetry (CV). The results revealed that the bipolar exfoliation provides high-quality rGO with promising characteristics suitable for aptasensors. The low cost and high efficiency of the process developed in this study are highly appealing features for POC biosensors. Several reasons—including the use of easily accessible and low-priced materials (i.e., graphite rods and DIW), the merging of several steps from other commonly practiced graphene biosensing application methods (i.e., exfoliation, reduction, and deposition) into one single step, and the elimination of the need for spacers such as CNTs due to the morphology of synthesized graphene (i.e., vertically aligned nanosheets)—make this process novel, economical, and highly efficient. Furthermore, the BPE technique was proven to be both versatile and amenable to mass production, thus making it a promising technique for various biotechnology applications, including but not limited to disposable cancer aptasensors and POC microdevices.
Prior to immobilizing aptamers, each electrode was examined with SEM to confirm the uniform deposition of rGO or GO on the electrodes. Next, amino-modified PDGF-BB affinity aptamers were immobilized on SS and PET/Au electrodes modified with BPE-graphene (Fig. 1b). The aptasensors were incubated with the desired PDGF-BB concentration at various temperatures ranging from 20 °C to 50 °C for between 10 and 150 minutes (Fig. 1c). The optimum incubation temperature was found to be 30 °C, and the optimum reaction time for target molecules to bind with aptamers was found to be 40 minutes. A three-electrode setup illustrated in Fig. 1d was used for CV and DPV evaluations of the electrodes. 5 mL aqueous electrolytes of 0.1 M PBS, 5 mM – K3Fe(CN)6, and different KCl concentrations in the range of 50 mM to 1 M were utilized for electrochemical analysis.
Electrochemical and FTIR characterization studies were conducted on four different BPE-treated SS electrodes referred to as SS/GO, SS/rGO, SS/GOApt, and SS/rGOApt, which represent the samples of GO deposited on the SS electrode (i.e., positive feeding electrode), rGO on deposited the SS electrode (i.e., negative feeding electrode), an aptamer immobilized on the SS/GO electrode, and an aptamer immobilized on SS/rGO electrode, respectively. An aptamer concentration of 15 μM was used to fabricate SS/GOApt, SS/rGOApt, and PET/Au/rGOApt electrodes studied in the following subsections except for PET/Au/rGOApt electrodes prepared for defining the optimum concentration of the aptamer. An optimum aptamer concentration of 10 μM was utilized to fabricate PET/Au/rGOApt electrodes studied in subsections 2.4. All BPE-treated electrodes had an effective area of 0.5 cm2 confined via bee's wax to minimize side reactions.
The TEM and selected area electron diffraction (SAED) images of BPE-rGO deposited on the TEM mesh are given in Fig. 2b. The TEM image shows that thin sheets of rGO (with overlaps or folds) with a span of approximately 400 nm are formed. Single crystalline SAED patterns confirm that less defective graphene sheets are formed during the bipolar exfoliation. Only a few diffraction spots beside the spots related to the crystal are formed, and no superlattice arrays are identified in the deposited graphene. Therefore, it can be concluded that the BPE-rGO is reduced and has high purity.40,41
Moreover, it has been reported that when the intensity of spots diffracted from the 〈210〉 planes is higher than the intensity of spots diffracted from the 〈100〉 planes, there is more than one layer stacked in the graphene material. It can be seen in the SAED pattern of the TEM image given in Fig. 2b that spots diffracted from the 〈210〉 planes (marked with green circles) have lower intensity than spots diffracted from the 〈100〉 planes (marked with yellow circles). The difference in the intensity of spots diffracted from the 〈210〉 planes and 〈100〉 planes suggests that the graphene deposited on the negative feeding electrode has a few layers.40,41 An interplanar spacing (also known as the d-spacing) of 0.2 nm is measured from the high-resolution TEM (HRTEM) image presented in Fig. 2c, in which the measured interplanar spacing is smaller than the typical value of GO.40,41
FTIR characterization was used to analyse the spectral data of the BPE-rGO and BPE-GO samples deposited on SS electrodes, including the formation of amide binding after aptamer immobilization. The FTIR spectra of the background, SS/GO, SS/rGO, SS/GOApt, and SS/rGOApt are represented in Fig. 3. The three samples of SS/GO, SS/GOApt, and SS/rGOApt showed a broad peak between 2800 and 3200 cm−1, which is ascribed to O–H stretching.42 The noteworthy peaks for all samples were identified at 1430 and 1600 cm−1, ascribed to C–O bending and aromatic CC stretching, respectively.43 Furthermore, all the samples showed peaks at 1100–1300 cm−1, which are attributed to sp3 C–H bending.42
The FTIR spectrum of SS/GOApt and SS/rGOApt confirms a peak at 1571 cm−1, associated with the amide II band, representing covalent bonding of PDGF-BB aptamers with BPE-graphene.42 The FTIR results confirm that the locally formed carboxyl groups on the graphene surfaces can be used directly to immobilize the amino-terminated biorecognition agents. The immobilization efficiency can also be improved using oxygen-plasma etching to increase the percentages of carboxyl groups on the surface of the BPE-graphene.1,44
In Fig. 4a, the CV curves measured for bare SS electrodes, four samples BPE treated electrodes, and subsequent aptasensors are presented. The CV curve of BPE-graphene deposited on the negative feeding electrode (i.e., SS/rGO) shows the highest peak currents and the largest CV curve area. The areal capacitances were calculated from CV curves using eqn (1):45
(1) |
In order to estimate the electrochemically active areas of BPE-rGO and BPE-GO using the Randles–Sevcik equation, the correlation of CV peak currents and the square root of the scan rate were studied to confirm the occurrence of a diffused-controlled process. The peak currents of CV measurements conducted on SS/rGO and SS/GO proportionally increased with the increase of scan rates at scan rates of 10–100 mV s−1 (CV curves are given in Fig. 4c and S2,† respectively). The CV peak currents of SS/rGO linearly increased with respect to the increase of the square root of the scan rates (Fig. 4d) with correlation coefficients (R2) of 0.9819 and 0.9822 for reduction peak currents and oxidation peak currents, respectively. Similarly, the linear dependence of the reduction and oxidation peak currents of SS/GO had R2 values of 0.9723 and 0.9891 for reduction and oxidation peak currents, respectively (the inset calibration plots in Fig. S2†). With the confirmation of the occurrence of a diffused-controlled process, the active surface areas of the BPE-rGO and BPE-GO samples were calculated using the Randles–Sevcik equation at room temperature (T = 295 K) (eqn (2)).46
IP = (2.69 × 105)n3/2ACD1/2ν1/2 | (2) |
The DPV responses of BPE-rGO and BPE-GO aptasensors at different development stages are given in Fig. 4e and f, respectively. The DPV response of SS/rGO shows a similar peak current to SSBare (i.e., SS electrode without any modifications) with values of 45.8 μA and 44.6 μA for SS/rGO and SSBare, respectively. These responses suggest a good electrochemical conductivity of deposited rGO on the SS electrode. However, the DPV response of SS/GO shows a decrease in peak current with a value of 37.9 μA, because of the structure of GO and the functional groups covering the surface of SS/GO. The DPV responses of SS/rGOApt and SS/GOApt show increased peak currents with values of 51 μA and 48.4 μA, respectively. The increase in peak currents after aptamer immobilization can be explained by the engagement of negatively charged carboxylate groups in covalent immobilization of aptamers and extinguished remaining functional groups by a Tween-20 quencher.47 The SS/rGOApt and SS/GOApt electrodes incubated with target molecules (i.e., SS/rGOApt+T and SS/GOApt+T) have considerably lower peak currents with values of 24 μA for SS/rGOApt+T and 26.5 μA for SS/GOApt+T, respectively. The decrease in peak currents is due to the isolative properties of the PDGF-BB oncoproteins, which decreases the passing of the redox species to the SS/rGOApt and SS/GOApt electrodes.48 Therefore, the DPV characterization of BPE-graphene-covered electrodes confirmed the successful entrapment of PDGF-BB oncoproteins on the surfaces of the envisioned aptasensors and that seizing of the target proteins decreases the peak current.
The optimum reaction time in aptasensors is referred to as the minimum time required for forming the aptamer–target complex that is both efficient and sufficiently quick. To find the optimum reaction time, the SS/rGOApt samples were incubated with 100 pM PDGF-BB for different periods ranging from 10–120 minutes and analysed by measuring the peak current of the DPV plot. As shown in Fig. 5a, the peak current decreases by increasing the incubation time up to 40 minutes and saturates afterward. Therefore, the optimum reaction time was found to be 40 minutes.
The effect of pH on DPV measurements was investigated by conducting DPV measurements on SS/rGOApt incubated with 100 pM PDGF-BB in the electrolyte of 0.2 M KCl/5 mM K3Fe(CN)6/0.1 M PBS with different pH values in the 5.5–8 range. As given in Fig. 5b, the peak response value was recorded at pH 7.5; thus, the sensing measurements were conducted in the electrolyte with pH 7.5. The incubation temperature effect on the peak current was studied by incubating an SS/rGOApt electrode with 100 pM PDGF-BB at different temperatures ranging from 25 °C to 50 °C. The attained results presented in Fig. 5c show that the highest peak current was achieved with incubation at 30 °C; hence, 30 °C was used as the optimum incubation temperature. The result of optimum supporting salt concentration analysis is presented in Fig. 5d. The highest peak current was recorded in the electrolyte with 200 mM KCl; therefore, 200 mM was chosen as the optimum KCl concentration.
The responses of SS/rGOApt to 0–10 nM PDGF-BB measured under optimum conditions are given in Fig. 5e. The peak current of DPV curves at E ≈ 0.6 V (vs. Ag/AgCl) decreases proportionally to the PDGF-BB concentration increase. The observed trend in peak current results from the increased charged transfer resistance due to the isolative properties of PDGF-BB oncoproteins.48 The calibration curve of peak currents measured from DPV curves is presented in Fig. 5f. The linear dependence of peak currents to the logarithm of PDGF-BB concentrations has a slop of −7.84 μA logc−1 and a R2 of 0.9981.
The correlation of the logarithm of the PDGF-BB concentration and SS/rGOApt peak current can be evaluated as follows (eqn (3)):
i = 41.05 − 7.84logc−1, r = 0.9977 | (3) |
(4) |
The responses of SS/GOApt to 0–10 nM PDGF-BB measured under optimum conditions reached their saturation point at a PDGF-BB concentration of 150 pM (see Fig. S3†). The most probable reason for the narrow range of SS/GOApt is the low amount of immobilized aptamers due to the limited active area. The sensing analysis of SS/rGOApt and SS/GOApt demonstrated that the BPE-graphene deposited on negative feeding electrodes, because of its highly porous morphology and higher quality, provides a more suitable material for biosensing application purposes. Hence, the PET/Au based aptasensors were developed using BPE-rGO.
In Fig. 6b, the DPV plots of aptasensors based on BPE-treaded PET/Au electrodes at different development stages are presented. The DPV results show a similar performance pattern to the DPV analysis of SS based electrodes, in which the deposition of BPE-rGO increased the DPV peak current of BPE-treaded PET/Au electrodes (designated as PET/Au/rGO) with a value of 22.2 μA compared to bare PET/Au electrodes (designated as PET/AuBare) with a peak current value of 12.04 μA. The DPV plot of PET/Au/rGO electrodes after aptamer immobilization (designated as PET/Au/rGOApt) shows an increase in peak current with a value of 27.45 μA, as discussed in Section 2.2.
The optimum aptamer concentration for PET/Au/rGO-based aptasensors was analyzed by measuring the DVP response of PET/Au/rGO based aptasensors prepared with a specific aptamer concentration to 100 pM PDGF-BB. A separate PET/Au/rGOApt electrode was prepared using an aptamer concentration ranging from 0.5–50 μM. As shown in Fig. 6c, the PET/Au/rGOApt aptasensor showed its peak DPV response in a sample prepared with an aptamer concentration of 10 μM, and the peak current saturated afterward. Hence, the 10 μM aptamer concentration was utilized for sensing performance analysis.
The responses of PET/Au/rGOApt to 0–20 nM PDGF-BB measured under optimum conditions are given in Fig. 6d. Similar to the sensing performances of aptasensors based on SS electrodes, the peak current of DPV curves decreases proportionally to the increase of PDGF-BB concentration. The calibration curve of peak currents measured from DPV curves is presented in Fig. 6e. The linear dependence of peak currents on the logarithm of PDGF-BB concentrations has a slop of −4.07 μA logc−1 and a R2 of 0.9884. The correlation of the PET/Au/rGOApt peak current with the logarithm of the PDGF-BB concentration can be assessed as follows (eqn (5)):
i = 20.06 − 4.07logc−1, r = 0.9854 | (5) |
The selectivity of the PET/Au/rGOApt electrodes was investigated via recording the response of the aptasensors to 1 μg mL−1 bovine serum albumin, and 10 nM of PDGF-BB oncoprotein isomers (i.e., PDGF-AB and PDGF-AA) along with 100 pM PDGF-BB. The concentrations of interference agents were chosen to be approximately 100 times higher than the concentrations of the target molecules. The DPV peak currents measured for selectivity are presented in Fig. 6f, in which the peak current was measured from the DPV curves and differentiated from the aptasensor's blank response. The DPV peak current of the PET/Au/rGOApt aptasensor to PDGF-BB was 6.71 and 5.83 times higher than that of PDGF-AA and PDGF-AB aptasensors, respectively. The higher response of the PET/Au/rGOApt aptasensor to BSA than PDGF-AA and PDGF-AB is attributed to the bigger size of this protein and higher physical adsorption of BSA on the surface of the PET/Au/rGOApt aptasensor.
The storage stability of the PET/Au/rGOApt aptasensor was analyzed by conducting continuous electrochemical measurements on PET/Au/rGOApt in response to 100 pM PDGF-BB every day. The DPV peak current of 25.4 μA of PET/Au/rGOApt to 100 pM PDGF-BB after 6 days was 91.02% of the initial capacitive response (23.12 μA), which implies that the envisioned aptasensor has adequate storage stability.
Table 1 summarizes the recently developed electrochemical PDGF-BB aptasensors. The current aptasensor exhibited a wide linear range. In comparison to similar labeled and label-free gold based electrodes, noticeable improvement in the linear range has been achieved. The linear response range of envisioned aptasensor based BPE-treaded PET/Au covers the healthy levels of PDGF-BB as well as elevated levels in patients with cancer diseases.52,53 Furthermore, the proposed aptasensors are sufficiently stable. It is worth noting that the attained LoD of detection of 0.65 pM (the equivalent of 1.29 pg mL−1) is adequately lower than the minimum cut-off point of 0.1 ng mL−1 for the healthy levels of PDGF-BB in human serums.54 In general, the proposed aptasensor provides a wide linear range with efficient accuracy (i.e., limit of detection) suitable for determining PDGF-BB levels in healthy patients and patients with cancer diseases.
Electrode | Modification | Technique | Detection strategy | LoD | Linear range | Stability | Ref. |
---|---|---|---|---|---|---|---|
a GCE: glassy carbon electrode; Cu-MOFs: Cu-based metal–organic frameworks; TpBD-COFs: 1,3,5-triformylphloroglucinol (Tp), benzidine (BD), covalent organic frameworks (COFs); HAP-NPs: hydroxyapatite nanoparticles; SWV: square wave voltammetry; C-MEMS: carbon-microelectromechanical systems; EIS: electrochemical impedance spectroscopy; AuNPs: gold nanoparticles. | |||||||
GCE | Cu-MOFs/TpBD-COFs | DPV | Label-free | 0.034 pg mL−1 | 0.0001–60 ng mL−1 | N/A | 50 |
HAP-NPs | SWV | Labeled: HAP-NPs | 50 fg mL−1 | 0.1 pg mL−1 to 10 ng mL−1 | N/A | 51 | |
C-MEMS thin film | Oxygen plasma etching | CV | Label-free | 7 pM | 0.01–50 nM | 90.34% after 10 days | 47 |
EIS | 1.9 pM | 0.005–50 nM | |||||
Au | AuNPs | SWV | Labeled: α-cyclodextrin | 0.52 nM | 0.52–1.52 nM | 96.4% after 7 days | 52 |
Graphene doped with silver nanoclusters | EIS | Label-free | 26.5 fM | 32.3 fM to 1.61 pM | 96.7% after 10 days | 53 | |
SS | BPE rGO | DPV | Label-free | 0.53 pM | 0.005–10 nM | 91.2% after 6 days | This work |
PET/Au | 0.65 pM | 0.0007–20 nM |
The envisioned disposable biosensor was a suggested concept to study the BPE-graphene compatibility for biotechnology applications. The simplicity of electrochemical bipolar exfoliation of graphene and the environmental friendliness of the process enabled high potential for other various applications, including but not limited to biofuel cells, batteries, and supercapacitors. It is worth noting that the envisioned technology requires further studies in order to be applicable for clinical settings. Several topics can be considered such as investigating the performance of the sensor in response to real samples collected from human blood (e.g., the effect of biofoulents) and possible integration of anti-biofouling materials on to the envisioned sensor, the robustness of the sensor under harsh and uncontrolled conditions (e.g., exposure to high or very low temperatures), and the challenges related to mass-production. Furthermore, integration of sensors with AI and IoT is another interesting topic for future studies.
Footnote |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/d1na00470k |
This journal is © The Royal Society of Chemistry 2021 |